Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

Boehringer Ingelheim

Status: Completed

Conditions: HIV Infections

Treatments: Drug: tipranavir

Study type: Observational

Funder types: Industry

Identifiers

NCT00615290

1182.127

Details and patient eligibility

About

To obtain information on clinical practices for patients treated by Aptivus in real life

Enrollment: 42 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• HIV positive patients for whom Aptivus treatment is initiated by their physician
• Aptivus SCP respect

Exclusion criteria

None if the inclusion criteria are respected: observational study